The 9th Annual Nordic-American
Healthcare Conference
March 26 – 27 2025
TIME: 8:00 AM - 5:00 PM EST
Location:
599 Lexington Ave @ 52nd St., New York City
A&O Shearman Conference Center
The leading US-Nordic healthcare investor conference in the United States
Welcome to the 9th Annual Nordic-American Healthcare Conference!
Biotech | Healthtech | Medtech | Pharma
Healthcare companies and investors converge at the Nordic-American Healthcare Conference (NAHC) to cultivate networks, foster innovation, and develop the next generation of medication, diagnostics, and healthcare tools.
US |Denmark | Sweden | Norway | Finland | Iceland
Hosted by:
Together with:
Hosted by the DNB//Back Bay Healthcare Partnership in collaboration with Nasdaq Nordic, NAHC 2025 stands as an exclusive, invitation-only event, and the largest US-Nordic healthcare conference in the US. NAHC serves as a premier platform, uniting large and mid-cap public and private IPO-ready US and Nordic life science companies. All presenting companies will showcase leading products that offer substantial advancements in patient care, making them highly appealing investment opportunities.
The 2025 conference offers sessions specializing in the areas of rare disease, cardiovascular and metabolic disorders, oncology, and medtech and features panel discussions to explore specific industry topics in-depth.
We take pride in the transformative impact of NAHC-presented companies and uphold stringent criteria for participation. NAHC operates on a no-fee basis, generously funded by organizations committed to advancing the most promising innovations in the market.
Together, we remain steadfast in our commitment to propelling the most promising Nordic healthcare innovations onto the global stage and we are proud to present them alongside highly relevant discussions and US-based companies that are complementary to their offerings.
Attendance at this event is strictly by invitation for qualified investors and active participants in the biopharma, medtech, healthtech and pharmaceutical sectors.
Join us in shaping the future of healthcare innovation!
DNB//Back Bay Partnership for Healthcare
The DNB//Back Bay Partnership provides healthcare companies with strategic guidance, M&A and partnering support and execution and capabilities in global capital markets and investment and commercial banking.
DNB//Back Bay’s weekly bulletin provides IPOs, follow-on offerings, M&A, and venture financing activity across the US and EU.